triethylenemelamine has been researched along with Cataract, Membranous in 4 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
PIRODDA, A | 1 |
CONKLIN, JW | 1 |
UPTON, AC | 1 |
CHRISTENBERRY, KW | 1 |
BĂ©trix, AF | 1 |
Thompson, RW | 1 |
Small, RC | 1 |
Stein, JJ | 1 |
4 other studies available for triethylenemelamine and Cataract, Membranous
Article | Year |
---|---|
[Experimental cataract induced by antimitotic drugs].
Topics: Antimitotic Agents; Cataract; Colchicine; Triethylenemelamine | 1957 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
[Tolerance to antimitotics introduced in to the anterior chamber of the cat's eye. I. Introduction and clinical observations].
Topics: Animals; Anterior Chamber; Cataract; Cats; Cornea; Dactinomycin; Endothelium; Female; Injections; Ir | 1974 |
Treatment of retinoblastoma.
Topics: Cataract; Child; Child, Preschool; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Metastasis; | 1972 |